Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B and Varying Degrees of Renal Impairment

NCT00071201 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT00071201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00071201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B and Varying Degrees of Renal Impairment
Lead sponsor
Gilead Sciences
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2003
Completion date
March 31, 2006
Enrollment
48
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b